Dr. Carol Swain has shown great engagement in her companies' stocks, with insider trading values climbing notably. Starting from $89,940 in March 2024, her reported trading increased each month, reaching $197,360 by September 2024. This steady rise reflects her deep...
Dr. Carol Swain has shown great engagement in her companies' stocks, with insider trading values climbing notably. Starting from $89,940 in March 2024, her reported trading increased each month, reaching $197,360 by September 2024. This steady rise reflects her deep commitment and confidence in the growth of NexPoint Residential Trust and NexPoint Real Estate Finance. As a CEO who does not take cash compensation, Swain’s financial stakes are tied to the performance of her companies, which might explain her proactive trading strategy. Such trades suggest not only a belief in the companies' future success but also a strategic approach to managing her personal wealth through stock ownership in a rising market.